Introduction
The notion that ''chronic'' pain is a phenomenon distinct from ''acute'' pain is widely accepted as common sense among both physicians and the lay public [1] . Yet, there is no definition of chronic pain that distinguishes it mechanistically from acute pain. Current working definitions of chronic pain, for the most part, resort to fixed temporal cut-offs after which point acute pain switches in name to chronic pain. The arbitrariness of this approach is amply emphasized by the range of calendar-based periods that are used, for example: 1 month [2], 3 months [3], 6 months [1] or 1 year [4] .
Clinical experience, however, suggests that the difference between acute and chronic pain is not arbitrary and that there can be a functional transition of pain states from acute to chronic [5] [6] [7] [8] . This transition seems to be associated with a time-dependent disconnection of the generation of pain from the initial tissue injury and decrease of responsiveness to some therapies that successfully treat acute pain [9] . Alternatively acute pain might persist for long periods without ever undergoing a ''chronicization'' [10] of its underlying mechanism.
Understanding the cellular mechanisms underlying chronic pain states will be a critical step in the development of new therapies to specifically target the distinct mechanisms of chronic pain. Numerous studies have implicated plastic changes in central nervous system circuitry, driven by increased activity in nociceptive primary afferent nerve fibers [11] . However, until recently, very little was known concerning the cellular changes underlying these very long-lasting alterations in excitability of primary afferents associated with chronic pain states.
In this review, we summarize a growing body of evidence that a transient insult can trigger long-lasting changes in primary afferent nociceptors, which prime them to become hyperresponsive to future mild insults that would normally not evoke pain in the unprimed state. The epsilon isoform of protein kinase C (PKCe) in the primary afferent nociceptor plays multiple crucial roles in this phenomenon [12] , known as ''hyperalgesic priming''. Emerging evidence suggests that hyperalgesic priming might not only be a basic pathophysiological mechanism of chronic re-injury pain but might also be key to understanding some of the most perplexing chronic pain conditions, including pain syndromes that are stress-related (e.g. fibromyalgia, irritable bowel syndrome or post-traumatic stress disorder) and neuropathic (e.g. associated with diabetes or chemotherapy for cancer or AIDS). Finally, we suggest that hyperalgesic priming is related to a broader range of other physiological phenomena in which excitable cells undergo PKCe-dependent priming in response to diverse insults.
Review
Glossary Cytokine: The term ''cytokine'' historically referred to proteins, such as interleukins and TNF-a, released from immune cells to modulate local cellular responses to injury, infection and inflammation. The current view of cytokines has broadened considerably. For example, in the context of hyperalgesic priming, epinephrine that is released in inflamed tissues where it sensitizes primary afferent nociceptors is considered to act as a cytokine. Fibromyalgia: The principal symptoms of fibromyalgia are chronic widespread pain and painful response to touch. The American College of Rheumatology defines the diagnosis of fibromyalgia by the presence of both: (i) history of widespread pain lasting more than 3 months-in all four quadrants of the body, i.e. both above and below the waist on both sides of the body; and (ii) pain can be elicited from at least 11 of 18 predefined points on the body (''tender points'') upon stimulation with 4 kg of force. Generalized pain syndrome: Generalized pain syndromes are a diverse group of disorders in which chronic pain is present in widespread areas of the body in the absence of any clear noxious stimulus. Some of the most prevalent generalized pain syndromes are fibromyalgia, irritable bowel syndrome and interstitial cystitis. Generalized pain is also an important and debilitating symptom in other disorders in which pain is not the foremost defining characteristic, including chronic fatigue syndrome and posttraumatic stress disorder. Many of these disorders are comorbid conditions, often occurring together in individual patients. Hyperalgesic priming: An operational definition of hyperalgesic priming is: a neuroplastic change in the primary afferent nociceptor that causes PGE 2 -induced hyperalgesia to last at least 24 h and to become dependent on PKCe. Nociceptor: A nociceptor is a sensory neuron giving rise to a small-diameter nerve fiber that is activated by noxious (potentially tissue damaging) stimuli. Activity in nociceptors usually elicits the human perception of pain. PKCe: A member of the ''novel'' class of protein kinase C isoforms that are activated by diacylglycerol or phorbol ester in a calcium-independent manner. 
